Anti-Obesity Prescription Drugs and Forecast Market

List of Tables
Table 1. Key Players of Anti-Obesity Prescription Drugs in Global Market
Table 2. Top Anti-Obesity Prescription Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Anti-Obesity Prescription Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Anti-Obesity Prescription Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Anti-Obesity Prescription Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Anti-Obesity Prescription Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Anti-Obesity Prescription Drugs Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Anti-Obesity Prescription Drugs Product Type
Table 9. List of Global Tier 1 Anti-Obesity Prescription Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Obesity Prescription Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Anti-Obesity Prescription Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Anti-Obesity Prescription Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Anti-Obesity Prescription Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Anti-Obesity Prescription Drugs Sales (K Units), 2024-2029
Table 16. By Application ? Global Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Anti-Obesity Prescription Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Anti-Obesity Prescription Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Anti-Obesity Prescription Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Anti-Obesity Prescription Drugs Sales (K Units), 2024-2029
Table 21. By Region ? Global Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Anti-Obesity Prescription Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Anti-Obesity Prescription Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Anti-Obesity Prescription Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Anti-Obesity Prescription Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Anti-Obesity Prescription Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Anti-Obesity Prescription Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Anti-Obesity Prescription Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Anti-Obesity Prescription Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Anti-Obesity Prescription Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Anti-Obesity Prescription Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Anti-Obesity Prescription Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Anti-Obesity Prescription Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Anti-Obesity Prescription Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Anti-Obesity Prescription Drugs Sales, (K Units), 2024-2029
Table 46. F Hoffmann La Roche Ltd Company Summary
Table 47. F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Product Offerings
Table 48. F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. F Hoffmann La Roche Ltd Key News & Latest Developments
Table 50. Orexigen Therapeutics Company Summary
Table 51. Orexigen Therapeutics Anti-Obesity Prescription Drugs Product Offerings
Table 52. Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Orexigen Therapeutics Key News & Latest Developments
Table 54. Novo Nordisk A/s Company Summary
Table 55. Novo Nordisk A/s Anti-Obesity Prescription Drugs Product Offerings
Table 56. Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Novo Nordisk A/s Key News & Latest Developments
Table 58. Arena Pharmaceuticals Company Summary
Table 59. Arena Pharmaceuticals Anti-Obesity Prescription Drugs Product Offerings
Table 60. Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Arena Pharmaceuticals Key News & Latest Developments
Table 62. Glaxosmithkline Company Summary
Table 63. Glaxosmithkline Anti-Obesity Prescription Drugs Product Offerings
Table 64. Glaxosmithkline Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Glaxosmithkline Key News & Latest Developments
Table 66. Vivus Company Summary
Table 67. Vivus Anti-Obesity Prescription Drugs Product Offerings
Table 68. Vivus Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Vivus Key News & Latest Developments
Table 70. Boehringer Ingelheim Company Summary
Table 71. Boehringer Ingelheim Anti-Obesity Prescription Drugs Product Offerings
Table 72. Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Boehringer Ingelheim Key News & Latest Developments
Table 74. Alizyme Company Summary
Table 75. Alizyme Anti-Obesity Prescription Drugs Product Offerings
Table 76. Alizyme Anti-Obesity Prescription Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Alizyme Key News & Latest Developments
Table 78. Anti-Obesity Prescription Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 79. Global Anti-Obesity Prescription Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 80. Global Anti-Obesity Prescription Drugs Production by Region, 2018-2023 (K Units)
Table 81. Global Anti-Obesity Prescription Drugs Production by Region, 2024-2029 (K Units)
Table 82. Anti-Obesity Prescription Drugs Market Opportunities & Trends in Global Market
Table 83. Anti-Obesity Prescription Drugs Market Drivers in Global Market
Table 84. Anti-Obesity Prescription Drugs Market Restraints in Global Market
Table 85. Anti-Obesity Prescription Drugs Raw Materials
Table 86. Anti-Obesity Prescription Drugs Raw Materials Suppliers in Global Market
Table 87. Typical Anti-Obesity Prescription Drugs Downstream
Table 88. Anti-Obesity Prescription Drugs Downstream Clients in Global Market
Table 89. Anti-Obesity Prescription Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anti-Obesity Prescription Drugs Segment by Type in 2022
Figure 2. Anti-Obesity Prescription Drugs Segment by Application in 2022
Figure 3. Global Anti-Obesity Prescription Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti-Obesity Prescription Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Anti-Obesity Prescription Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Anti-Obesity Prescription Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Anti-Obesity Prescription Drugs Revenue in 2022
Figure 9. By Type - Global Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Anti-Obesity Prescription Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Anti-Obesity Prescription Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Anti-Obesity Prescription Drugs Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Anti-Obesity Prescription Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Anti-Obesity Prescription Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Anti-Obesity Prescription Drugs Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Anti-Obesity Prescription Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Anti-Obesity Prescription Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Anti-Obesity Prescription Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Anti-Obesity Prescription Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Anti-Obesity Prescription Drugs Sales Market Share, 2018-2029
Figure 23. US Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Anti-Obesity Prescription Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Anti-Obesity Prescription Drugs Sales Market Share, 2018-2029
Figure 28. Germany Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Anti-Obesity Prescription Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Anti-Obesity Prescription Drugs Sales Market Share, 2018-2029
Figure 37. China Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Anti-Obesity Prescription Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Anti-Obesity Prescription Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Anti-Obesity Prescription Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Anti-Obesity Prescription Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Anti-Obesity Prescription Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Anti-Obesity Prescription Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Anti-Obesity Prescription Drugs by Region, 2022 VS 2029
Figure 54. Anti-Obesity Prescription Drugs Industry Value Chain
Figure 55. Marketing Channels